• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Epidemiol Infect . Sex differences in response to COVID-19 mRNA vaccines in Italian population

tetano

Editor, Senior Moderator
Epidemiol Infect


. 2024 Nov 18:152:e139.
doi: 10.1017/S0950268824001079. Sex differences in response to COVID-19 mRNA vaccines in Italian population

Eliana Ferroni[SUP] 1 [/SUP], Alberto Mateo-Urdiales[SUP] 2 [/SUP], Carla Bietta[SUP] 3 [/SUP], Giulia Cesaroni[SUP] 4 [/SUP], Simona Anticoli[SUP] 5 [/SUP], Elisa Di Maggio[SUP] 2 6 [/SUP], Angela Ancona[SUP] 2 7 [/SUP], Daniele Petrone[SUP] 2 [/SUP], Andrea Cannone[SUP] 2 [/SUP], Chiara Sacco[SUP] 2 [/SUP], Massimo Fabiani[SUP] 2 [/SUP], Martina Del Manso[SUP] 2 [/SUP], Flavia Riccardo[SUP] 2 [/SUP], Antonino Bella[SUP] 2 [/SUP], Anna Ruggieri[SUP] 5 [/SUP], Patrizio Pezzotti[SUP] 2 [/SUP]



Affiliations
Abstract

Since the beginning of mass vaccination campaign for COVID-19 in Italy (December 2020) and following the rapidly increasing vaccine administration, sex differences have been emphasized. Nevertheless, incomplete and frequently incoherent sex-disaggregated data for COVID-19 vaccinations are currently available, and vaccines clinical studies generally do not include sex-specific analyses for safety and efficacy. We looked at sex variations in the COVID-19 vaccine's effectiveness against infection and severe disease outcomes. We conducted a nationwide retrospective cohort study on Italian population, linking information on COVID-19 vaccine administrations obtained through the Italian National Vaccination Registry, with the COVID-19 integrated surveillance system, held by the Istituto Superiore di Sanità. The results showed that, in all age groups, vaccine effectiveness (VE) was higher in the time-interval ≤120 days post-vaccination. In terms of the sex difference in vaccination effectiveness, men and women were protected against serious illness by vaccination in a comparable way, while men were protected against infection to a somewhat greater extent than women. To fully understand the mechanisms underlying the sex difference in vaccine response and its consequences for vaccine effectiveness and development, further research is required. The sex-related analysis of vaccine response may contribute to adjust vaccination strategies, improving overall public health programmes.

Keywords: COVID-19; Italy; female; male; sex difference; vaccine.

 
Back
Top Bottom